title: Potential efficacy of cell-penetrating peptides for nucleic acid and drug delivery in cancer.
abstract: Cell penetrating peptides (CPPs) are short amphipathic and cationic peptides that are rapidly internalized across cell membranes. They can be used to deliver molecular cargo, such as imaging agents (fluorescent dyes and quantum dots), drugs, liposomes, peptide/protein, oligonucleotide/DNA/RNA, nanoparticles and bacteriophage into cells. The utilized CPP, attached cargo, concentration and cell type, all significantly affect the mechanism of internalization. The mechanism of cellular uptake and subsequent processing still remains controversial. It is now clear that CPP can mediate intracellular delivery via both endocytic and non-endocytic pathways. In addition, the orientation of the peptide and cargo and the type of linkage are likely important. In gene therapy, the designed cationic peptides must be able to 1) tightly condense DNA into small, compact particles; 2) target the condensate to specific cell surface receptors; 3) induce endosomal escape; and 4) target the DNA cargo to the nucleus for gene expression. The other studies have demonstrated that these small peptides can be conjugated to tumor homing peptides in order to achieve tumor-targeted delivery in vivo. On the other hand, one of the major aims in molecular cancer research is the development of new therapeutic strategies and compounds that target directly the genetic and biochemical agents of malignant transformation. For example, cell penetrating peptide aptamers might disrupt protein-protein interactions crucial for cancer cell growth or survival. In this review, we discuss potential functions of CPPs especially for drug and gene delivery in cancer and indicate their powerful promise for clinical efficacy.
authors.affiliation: Molecular Immunology and Vaccine Research Laboratory, Pasteur Institute of Iran, Tehran, Iran. azam_bolhassani@yahoo.com
authors.forename: Azam
authors.initials: A
authors.lastname: Bolhassani
mesh_terms: D000595:Amino Acid Sequence; D057846:Cell-Penetrating Peptides / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D016503:Drug Delivery Systems; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D008081:Liposomes; D008969:Molecular Sequence Data; D009369:Neoplasms / Q000628:therapy*; D019913:Nuclear Localization Signals; D014611:Vaccination; D019444:Vaccines, DNA / Q000008:administration & dosage
chemical_list: D057846:Cell-Penetrating Peptides; D008081:Liposomes; D019913:Nuclear Localization Signals; D019444:Vaccines, DNA